AbstractNine inherited neurodegenerative disorders result from polyglutamine expansions. Two recently published papers on spinocerebellar ataxia type 1, together with studies on spinobulbar muscular atrophy last year, indicate that host protein context is the key arbiter of polyglutamine disease protein toxicity. This insight may represent the most important development in the field since the recognition of nuclear inclusions or the propensity of polyglutamine to aggregate. Indeed, an intimate and inextricable relationship may exist between polyglutamine neurotoxicity and the normal interactions, domains, modifications, and functions of the respective disease proteins
AbstractFive neurodegenerative diseases are caused by proteins with expanded polyglutamine domains. ...
Huntington disease and other diseases of polyglutamine expansion are each caused by a different prot...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
Expansion of CAG trinucleotide repeats coding for polyglutamine in unrelated proteins causes at leas...
Polyglutamine diseases are caused by an expanded glutamine domain thought to confer a toxic activity...
Proteolytic cleavage has been implicated in the pathogenesis of diverse neurodegenerative diseases i...
Although the genetic basis of polyglutamine diseases has been recognized for 20 years, their molecul...
AbstractThe mechanisms of neurodegeneration in the CAG repeat polyglutamine diseases, including Spin...
Polyglutamine expansions in certain proteins are the genetic determinants for nine distinct progress...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
The polyglutamine (polyQ) diseases, such as Huntington’s disease and several types of spinocerebella...
Polyglutamine diseases are neurodegenerative disorders caused by expansion of polyglutamine tracts i...
Polyglutamine diseases are a family of nine neurodegenerative disorders caused by expansion in diffe...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
SummaryPolyglutamine expansion diseases are triggered by the accumulation of toxic proteins. A new s...
AbstractFive neurodegenerative diseases are caused by proteins with expanded polyglutamine domains. ...
Huntington disease and other diseases of polyglutamine expansion are each caused by a different prot...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
Expansion of CAG trinucleotide repeats coding for polyglutamine in unrelated proteins causes at leas...
Polyglutamine diseases are caused by an expanded glutamine domain thought to confer a toxic activity...
Proteolytic cleavage has been implicated in the pathogenesis of diverse neurodegenerative diseases i...
Although the genetic basis of polyglutamine diseases has been recognized for 20 years, their molecul...
AbstractThe mechanisms of neurodegeneration in the CAG repeat polyglutamine diseases, including Spin...
Polyglutamine expansions in certain proteins are the genetic determinants for nine distinct progress...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
The polyglutamine (polyQ) diseases, such as Huntington’s disease and several types of spinocerebella...
Polyglutamine diseases are neurodegenerative disorders caused by expansion of polyglutamine tracts i...
Polyglutamine diseases are a family of nine neurodegenerative disorders caused by expansion in diffe...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
SummaryPolyglutamine expansion diseases are triggered by the accumulation of toxic proteins. A new s...
AbstractFive neurodegenerative diseases are caused by proteins with expanded polyglutamine domains. ...
Huntington disease and other diseases of polyglutamine expansion are each caused by a different prot...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...